26 June 2016

4imprint improves as Nelson nails 'Cessna' deal

10/01/03

Shares in promotional products distributor 4imprint (FOUR) improved 3p to 36.5p today, after the support services outfit flagged up a new contract with Cessna Aircraft Company and CEO Dick Nelson said its full year result would match market expectations.

4imprint (FOUR) has been chosen to supply promotional products for Cessna's on-site store in Kansas, as well as to manage and stock the store, which is open to Cessna employees and visitors. Nelson's Whitefield-headquartered company has also set up an online store for Cessna, a division of Fortune 500 outfit Textron that designs and makes light and mid-size business jets as well as single engine piston aircraft.

4imprint consists of a batch of companies in the highly fragmented promotional products market worth some $30 billion. Globally its the biggest direct marketer of these products and the fourth largest distributor, with blue chip clents like BT, British Airways, Microsoft and BMW on its books.

In other, more upbeat news, Nelson says 4Imprints full year figures due out in mid-March will hit reduced market forecasts. 'The advertising market remains challenging, but we're beginning to see the benefits of tighter controls and growth plans we put in place last year, and our cash generation in 2002 has been better than expected' he added.

Last September, 4imprint's interims to 29 June were a big disappointment. Pre-tax profits of 500,000 reversed to a 2.3 million deficit after a 2.4 million provision against amounts owed from US franchisee owners. Following a review of the operation, management had targeted a number of 'underperforming or non-compliant' owners for temination at its US franchise Adventures in Advertising.

Even the profit before tax, exceptionals and goodwill measure crashed 45 per cent to a mere 520,000, on turnover 1.4 per cent softer at 45 million, as 4imprint endured 'the worst conditions seen in advertising in recent history'.

However, with the now reduced forecasts likely to be met, and the shares still languishing, analyst Charlie Cottam at house broker WestLB Panmure has an 'outperform' note out on the stock with a 60p target price. He has 5.6p of earnings pencilled in for the year to 29 December 2002, down from 8.9p, and expects pre-tax profits of 2.5 million (trimmed back from previous estimates of 3.9 million). At 36.5p, the shares trade on a mere 6.5 times earnings.

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Stadium hit by profit warning 23/06/16

Stadium Group shares have been hit by a profit warning. This is a particular blow given the company’s progress in repositioning itself into a higher quality, design-led business.

Verona raises £42m to fund drug trials  19/06/16

Verona Pharma (AIM: VRP) has raised an impressive £42 million net of costs which will fund phase II trials for its RPL554 compound. This drug targets severe respiratory diseases, in particular the 65 million worldwide sufferers from COPD (chronic obstructive pulmonary disease).

Income attractions at Belvoir 15/06/16

It’s fair to say that buy-to-let landlords have been under George Osborne’s cosh. He’s introduced a raised stamp duty rate and withdrawn higher-rate tax relief. However, Belvoir Lettings has seen little change in the market as far as its core lettings agency business is concerned. Furthermore, the shares have responded positively to a major acquisition which makes Belvoir the largest UK lettings agent.

Wincanton keeps on trucking 12/06/16

Wincanton CEO Adrian Colman feels his company is now back on an even keel after a period of fire-fighting. Debt has been brought under control, the pension deficit is being addressed, and onerous leases and contracts have been dealt with. A return to the dividend list illustrates these positive changes and the fact that management can now fully focus on growing the business.

VP maintains its reputation for quality   09/06/16

Plant hire company VP continues to perform well against a mixed backdrop. Management said that the core infrastructure, housing and construction markets remained generally supportive and have offset weakness in oil and gas.

Redhall on the road back to profitability  08/06/16

Redhall's interim results show the turnround at this specialist engineer is on track. The growth in the order book is particularly encouraging and lends credibility to forecasts of a significant return to profitability over the next couple of years.

More News